Association Between Genetically Proxied Lipid-Lowering Drug Targets and Renal Cell Carcinoma: A Mendelian Randomization Study

Observational studies suggested inconsistent associations between lipid-lowering drugs, such as statins, and renal cell carcinoma (RCC) risk. In a two-sample Mendelian randomization (MR) framework, we assessed the causal influence of lipid-lowering agents and circulating lipid traits on overall and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Luyang, Sheng, Chao, Lyu, Zhangyan, Dai, Hongji, Chen, Kexin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545796/
https://www.ncbi.nlm.nih.gov/pubmed/34712689
http://dx.doi.org/10.3389/fnut.2021.755834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545796/
https://www.ncbi.nlm.nih.gov/pubmed/34712689
http://dx.doi.org/10.3389/fnut.2021.755834

Ejemplares similares